Display Settings:

Format

Send to:

Choose Destination
    J Hematol Oncol. 2008 Jun 28;1:7.

    Rosai dorfman disease of the orbit.

    Source

    Ophthalmic Pathology Service, Hyderbad Eye Research Centre, L V Prasad Eye Institute, Hyderbad, India. geeta@lvpei.org

    Abstract

    OBJECTIVE:

    To report the clinico-histopathologic features, management and outcome of Rosai-Dorfman disease of the orbit.

    DESIGN:

    Non-comparative case series.

    RESULTS:

    Rosai-Dorfman disease of the orbit constituted 0.09% of all ocular specimens received at our Institute, presenting with a firm rubbery mass causing proptosis; bilateral in 4 (57%) cases. The median age at presentation was 13 years (range 5-65); median duration of symptoms was 6 (range 3-15) years. Lymphadenopathy was noted in 4 (57%); extranodal involvement in 3 (43%). After biopsy, 3 cases were treated with systemic corticosteroids, 2 cases developed local recurrence that responded to systemic corticosteroid therapy. Polymorphous population of lymphocytes, plasma cells, and characteristic S-100-positive histiocytes showing emperipolesis were pathognomonic histologic features.

    CONCLUSION:

    Rosai-Dorfman disease of the orbit, although rare, should be considered in young individuals with chronic proptosis with rubbery masses. Excision and corticosteroid therapy provide a favorable outcome.

    PMID:
    18588698
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2474646
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 5
    Figure 6
    Figure 2
    Figure 3
    Figure 1
    Figure 4

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk